Cell Impact マネジメント

マネジメント基準チェック /14

Cell Impactの CEO はDaniel Vallinで、 Jan2024年に任命され、の在任期間は 1 年未満です。は、会社の株式の0.077%を直接所有しており、その価値はSEK 95.76K 。経営陣と取締役会の平均在任期間はそれぞれ2年と1.6年です。

主要情報

Daniel Vallin

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	0.08%
経営陣の平均在職期間	2yrs
取締役会の平均在任期間	1.6yrs

経営陣の近況

Recent updates

Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?

May 13

Is Cell Impact (STO:CI) Using Debt In A Risky Way?

Jan 14

Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation

May 09

Investors Who Bought Cell Impact (STO:CI B) Shares Three Years Ago Are Now Up 428%

Feb 21

How Much Is Cell Impact AB (publ) (STO:CI B) Paying Its CEO?

Dec 27

CEO（最高経営責任者

Daniel Vallin (47 yo)

less than a year

在職期間

Mr. Daniel Vallin serves as Chief Executive Officer since October 1, 2024 and served as its Acting Chief Executive Officer since January 1, 2024 until October 1, 2024 and was Chief Operating Officer at Cel...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Daniel Vallin	Chief Executive Officer	less than a year	データなし	0.077% SEK 95.8k
Malin Lundberg	Chief Financial Officer	less than a year	データなし	データなし
Anders Öberg	Chief Technology Officer	6.8yrs	データなし	データなし
Marcus Nilsson	Sales & Program Manager	no data	データなし	データなし
Karina Larsson	Chief Human Resource Officer	3.2yrs	データなし	0.0023% SEK 2.8k
Shigeru Nakagawa	Managing Director of Cell Impact Japan Inc.	3.8yrs	データなし	0.016% SEK 19.4k
Henrik Jackman	Chief Application Engineer	less than a year	データなし	データなし

2.0yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: CIの経営陣は経験豊富であると考えられます ( 2年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Thomas Carlstrom	Director	7.8yrs	SEK 86.00k	0.078% SEK 96.7k
Mats Boquist	Director	less than a year	データなし	データなし
Mats Franzén	Chairman of the Board	1.6yrs	データなし	0.29% SEK 355.3k
Lars Bergstrom	Director	2.8yrs	データなし	0.15% SEK 187.9k
Jan Pieters	Director	less than a year	データなし	データなし

1.6yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: CIの取締役会は経験豊富ではない ( 1.6年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Cell Impact マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Chairman of the Board exercised options to buy kr76k worth of stock.

Cell Impact AB (Publ) Announces Daniel Vallin as the Permanent CEO, Effective from October 1, 2024

Director recently bought kr125k worth of stock

Cell Impact AB (Publ) Announces Board and Committee Changes

Director recently bought kr91k worth of stock

Cell Impact AB (Publ) Appoints Henrik Jackman as Chief Application Engineer

Recent updates

Cell Impact AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025

Chairman of the Board exercised options to buy kr76k worth of stock.

Cell Impact AB (Publ) Announces Daniel Vallin as the Permanent CEO, Effective from October 1, 2024

Director recently bought kr125k worth of stock

Second quarter 2024 earnings released

Cell Impact AB (Publ) Provides Earnings Guidance for the Year 2027 and 2030

Cell Impact Adds Sealing as A New Part of Production Process

New major risk - Share price stability

First quarter 2024 earnings released: kr0.04 loss per share (vs kr0.40 loss in 1Q 2023)

Cell Impact AB (Publ) Announces Board and Committee Changes

Director recently bought kr91k worth of stock

Full year 2023 earnings released: kr1.11 loss per share (vs kr1.38 loss in FY 2022)

Cell Impact AB (Publ) Appoints Henrik Jackman as Chief Application Engineer

Chief Executive Officer recently bought kr50k worth of stock

Cell Impact AB (publ) Announces CEO Changes

New major risk - Shareholder dilution

Cell Impact AB (Publ) Announces That Stefan Axellie to Leave Role as CFO

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.38 loss in 3Q 2022)

Cell Impact AB (Publ) Announces Preliminary Earnings Guidance for Third Quarter 2023

New major risk - Market cap size

Cell Impact AB (publ) Announces Anna Frick Will Leave the Board

Chief Executive Officer recently bought kr101k worth of stock

Cell Impact AB (publ) Provides Earnings Guidance for the Year 2025 and 2028

Cell Impact AB (Publ) Announces Outstanding Measuring Precision Enabling Customers' Product Development

New major risk - Share price stability

Chief Executive Officer recently bought kr50k worth of stock

Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?

Full year 2022 earnings released: kr1.38 loss per share (vs kr1.35 loss in FY 2021)

Cell Impact AB (publ) to Report Fiscal Year 2023 Results on Mar 24, 2024

Is Cell Impact (STO:CI) Using Debt In A Risky Way?

No independent directors

Third quarter 2022 earnings released: kr0.38 loss per share (vs kr0.25 loss in 3Q 2021)

Second quarter 2022 earnings released

Cell Impact AB (publ) PUBL SHARE AK B to Be Deleted from Other OTC

First quarter 2022 earnings released

No independent directors

Full year 2021 earnings released: kr1.35 loss per share (vs kr0.88 loss in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Cell Impact AB (publ) to Report Q2, 2022 Results on Aug 25, 2022

Third quarter 2021 earnings released

Second quarter 2021 earnings released

Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation

First quarter 2021 earnings released

Cell Impact AB (publ) Receives SEK 42 Million Order from Plug Power for New Production Line and Flow Plates

Investors Who Bought Cell Impact (STO:CI B) Shares Three Years Ago Are Now Up 428%

Full year 2020 earnings released: kr0.85 loss per share (vs kr1.45 loss in FY 2019)

New 90-day high: kr49.70

Cell Impact Appoints Forrest Zhang as Country Manager in China, Effective May 3, 2021

How Much Is Cell Impact AB (publ) (STO:CI B) Paying Its CEO?

New 90-day high: kr29.30

New 90-day high: kr29.00

Third quarter 2020 earnings released: kr0.12 loss per share

New 90-day low: kr21.35

Cell Impact AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 175 million.

First half earnings released

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14